Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

Clinical trial NCT06180174 · RECRUITING

Trial details

NCT number: NCT06180174
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B Cell Lymphoma Non Hodgkin Lymphoma

Start date: 2023-12-31
Primary completion: 2025-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.